Company / Inventory
Merck & Co. Inventory History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$6.7B
FY2025
5-year range
$5.9B / $6.7B
FY2021-FY2025
Trend
+9.0%
vs FY2024
Sector context
#4 of 105
Health Care
What the data says
Among 105 Health Care companies, Merck & Co. is in the top 4% for inventory. Inventory has fluctuated over the past 10 years, ranging from $4.9B in FY2016 to $6.7B in FY2025.
Based on SEC 10-K filings.
$6.7B in FY2025 with a 5-year CAGR of +3.7%. Top quartile in the Health Care sector.
Improved from $6.4B to $6.7B over the past 2 years.
Health Care sector context is included.
Inventory over time
Growth rates
- 3-Year CAGR
- +4.0%
- 5-Year CAGR
- +3.7%
- 10-Year CAGR
- -
Sector benchmark
Top 4% in Health CareTop 4% of 105This company $6.7B Sector average $885.3M
▼
+652.1% above sector average
Key checks
Key Insights
- 5-year CAGR of +3.7%, indicating consistent growth.
- In FY2025, inventory increased 9.0% year-over-year.
- Ranks #4 out of 105 companies in the Health Care sector.
- Lowest inventory in the period was in FY2016.
Company context
Key Data Points
- Strong profit margin: 29.6%
- Strong return on equity: 36.7%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.7B | +9.0% |
| FY2024 | $6.1B | -3.9% |
| FY2023 | $6.4B | +7.6% |
| FY2022 | $5.9B | -0.7% |
| FY2021 | $6.0B | +7.2% |
| FY2020 | $5.6B | -7.1% |
| FY2019 | $6.0B | +9.9% |
| FY2018 | $5.4B | +6.8% |
| FY2017 | $5.1B | +4.7% |
| FY2016 | $4.9B | +3.5% |
As of FY2025 · SEC 10-K · Updated Mar 9, 2026